Citations

Citations to this article as recorded by  

• Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus
  Megolhubino Terhüja, Manjunath Siddappa, Pramila Lamichhane, Chetan D. Meshram, Timothy A. Snider, Jerry W. Ritchey, Antonius G. P. Oomens
  Viruses.2024; 16(6): 843.     CrossRef
• Immune Response to Respiratory Viral Infections
  Antonella Gambadauro, Francesca Galletta, Alessandra Li Pomi, Sara Manti, Giovanni Piedimonte
  International Journal of Molecular Sciences.2024; 25(11): 6178.     CrossRef
• Viral Genetic Determinants of Prolonged Respiratory Syncytial Virus Infection Among Infants in a Healthy Term Birth Cohort
  Dylan Lawless, Christopher G McKennan, Suman R Das, Thomas Junier, Zhi Ming Xu, Larry J Anderson, Tebeb Gebretsadik, Meghan H Shilts, Emma Larkin, Christian Rosas-Salazar, James D Chappell, Jacques Fellay, Tina V Hartert
  The Journal of Infectious Diseases.2023; 227(10): 1194.     CrossRef
• Circulation pattern and genetic variation of human respiratory syncytial virus in China during 2008–2021
  Jingjing Song, Zhen Zhu, Jinhua Song, Naiying Mao, Aili Cui, Wenbo Xu, Yan Zhang
  Journal of Medical Virology.2023;[Epub]     CrossRef
• Repurposing Axl Kinase Inhibitors for the Treatment of Respiratory Syncytial Virus Infection
  Dan Zhang, Yuanhui Zhao, Xiaoxin You, Susu He, Erguang Li
  Antimicrobial Agents and Chemotherapy.2023;[Epub]     CrossRef
• Activation of the Chemokine Receptor CCR1 and Preferential Recruitment of Gαi Suppress RSV Replication: Implications for Developing Novel Respiratory Syncytial Virus Treatment Strategies
  Jiao Li, Ling Xue, Jiachao Wang, Aihong Meng, Jiajun Qiao, Miao Li, Xiuli Wang, Lingtong Meng, Jingyuan Ning, Xue Gao, Wenjian Li, Cuiqing Ma, Lin Wei, Bryan R. G. Williams
  Journal of Virology.2022;[Epub]     CrossRef
• Mutation in the CX3C Motif of G Protein Disrupts Its Interaction with Heparan Sulfate: A Calorimetric, Spectroscopic, and Molecular Docking Study
  Abu Hamza, Abdus Samad, Zahoor Ahmad Parray, Sajda Ara, Anwar Ahmed, Fahad N. Almajhdi, Tajamul Hussain, Asimul Islam, Shama Parveen
  International Journal of Molecular Sciences.2022; 23(4): 1950.     CrossRef
• Innate Immune Responses to RSV Infection Facilitated by OGG1, an Enzyme Repairing Oxidatively Modified DNA Base Lesions
  Xu Zheng, Ke Wang, Lang Pan, Wenjing Hao, Yaoyao Xue, Attila Bacsi, Spiros A. Vlahopoulos, Zsolt Radak, Tapas K. Hazra, Allan R. Brasier, Lloyd Tanner, Xueqing Ba, Istvan Boldogh
  Journal of Innate Immunity.2022; 14(6): 593.     CrossRef
• Enhancing Anti-G Antibody Induction by a Live Single-Cycle Prefusion F—Expressing RSV Vaccine Improves In Vitro and In Vivo Efficacy
  Pramila Lamichhane, Megolhubino Terhüja, Timothy A. Snider, Antonius G. P. Oomens
  Viruses.2022; 14(11): 2474.     CrossRef
• Axl Mediates Resistance to Respiratory Syncytial Virus Infection Independent of Cell Attachment
  Dan Zhang, Yuanhui Zhao, Lingling Wang, Xiaoxin You, Jingjing Li, Guohai Zhang, Yayi Hou, Hongwei Wang, Susu He, Erguang Li
  American Journal of Respiratory Cell and Molecular Biology.2022; 67(2): 227.     CrossRef
• A live single-cycle RSV vaccine expressing prefusion F protein
  Pramila Lamichhane, Megan E. Schmidt, Megolhubino Terhüja, Steven M. Varga, Timothy A. Snider, Christina A. Rostad, Antonius G.P. Oomens
  Virology.2022; 577: 51.     CrossRef
• Biophysical studies of the interaction of hRSV Non-Structural 1 protein with natural flavonoids and their acetylated derivatives by spectroscopic techniques and computational simulations
  Isabella Ottenio de Lourenço, Evelyn Toscano Pedroso Quintino, Matheus Henrique Pereira, Caroline Sprengel Lima, Gabriela Campos Araújo, Luis Octávio Regasini, Fernando Alves de Melo, Fátima Pereira de Souza, Marcelo Andres Fossey, Ícaro Putinhon Caruso
  Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2022; 283: 121751.     CrossRef
• Pratensein glycoside attenuates respiratory syncytial virus infection-induced oxidative and inflammatory injury via TGF-β signaling pathway
  Qiong Zhang, Si Li, Qiong Huang
  Molecular & Cellular Toxicology.2022; 18(3): 329.     CrossRef
• Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies
  Harrison C. Bergeron, Jackelyn Murray, Ana M. Nuñez Castrejon, Rebecca M. DuBois, Ralph A. Tripp
  Viruses.2021; 13(2): 352.     CrossRef
• Juvenile, but Not Adult, Mice Display Increased Myeloid Recruitment and Extracellular Matrix Remodeling during Respiratory Syncytial Virus Infection
  Gerald G. Kellar, Stephen R. Reeves, Kaitlyn A. Barrow, Jason S. Debley, Thomas N. Wight, Steven F. Ziegler
  The Journal of Immunology.2020; 205(11): 3050.     CrossRef
• Double-edged role of natural killer cells during RSV infection
  Rauf Bhat, Mohamed A. Farrag, Fahad N. Almajhdi
  International Reviews of Immunology.2020; 39(5): 233.     CrossRef
• Disease severity of respiratory syncytial virus (RSV) infection correlate to a novel set of five amino acid substitutions in the RSV attachment glycoprotein (G) in China
  Wanwei Li, Yanlan Wang, Bo Yu, Qiqi Tan, Jijian Zhou, Jingjing Hu, Yuanbin Wu, Bo Wang, Hongjian Li
  Virus Research.2020; 281: 197937.     CrossRef
• Revisiting respiratory syncytial virus’s interaction with host immunity, towards novel therapeutics
  C. Efstathiou, S. H. Abidi, J. Harker, N. J. Stevenson
  Cellular and Molecular Life Sciences.2020; 77(24): 5045.     CrossRef
• Ephedrannin B exerts anti-viral and anti-inflammatory properties in BEAS-2B cells infected with respiratory syncytial virus
  Shu Hou, Xiaoyan Xu, Yating Wang, Yan Yang
  Journal of Biosciences.2020;[Epub]     CrossRef
• Vaccine containing G protein fragment and recombinant baculovirus expressing M2 protein induces protective immunity to respiratory syncytial virus
  Yeong-Min Jo, Jungwoo Kim, Jun Chang
  Clinical and Experimental Vaccine Research.2019; 8(1): 43.     CrossRef
• VITAMIN D LEVEL IN CRITICALLY ILL CHILDREN 6 MONTHS–5 YEARS AGE ADMITTED TO INTENSIVE CARE UNIT IN TERTIARY CARE HOSPITAL OF CENTRAL INDIA
  AKSHAY ASHOK ., MANJUSHA GOEL ., BHARTI CHAUBEY ., RAJESH PATIL .
  Indian Journal of Child Health.2019; 06(04): 413.     CrossRef
• Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection
  Mariana Guerra-Maupome, Mitchell V. Palmer, Jodi L. McGill, Randy E. Sacco
  Vaccines.2019; 7(1): 7.     CrossRef
• Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development
  Seyhan Boyoglu-Barnum, Tatiana Chirkova, Larry J. Anderson
  Frontiers in Immunology.2019;[Epub]     CrossRef
• Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze
  Kedir N. Turi, Jyoti Shankar, Larry J. Anderson, Devi Rajan, Kelsey Gaston, Tebeb Gebretsadik, Suman R. Das, Cosby Stone, Emma K. Larkin, Christian Rosas-Salazar, Steven M. Brunwasser, Martin L. Moore, R. Stokes Peebles, Tina V. Hartert
  American Journal of Respiratory and Critical Care Medicine.2018; 198(8): 1064.     CrossRef
• Hydrogen sulfide in physiology and pathogenesis of bacteria and viruses
  Virender Kumar Pal, Parijat Bandyopadhyay, Amit Singh
  IUBMB Life.2018; 70(5): 393.     CrossRef

Citations

Citations to this article as recorded by  

• Scale-Up of COVID-19 Testing Services in NYC, 2020–2021: Lessons Learned to Maximize Reach, Equity and Timeliness
  Lorna E. Thorpe, Sarah Conderino, Stefanie Bendik, Carolyn Berry, Nadia Islam, Rachel Massar, Michelle Chau, Rita Larson, Margaret M. Paul, Chuan Hong, Andrew Fair, Andrea R. Titus, Anna Bershteyn, Andrew Wallach
  Journal of Urban Health.2024; 101(5): 913.     CrossRef
• An individual level infectious disease model in the presence of uncertainty from multiple, imperfect diagnostic tests
  Caitlin Ward, Grant D. Brown, Jacob J. Oleson
  Biometrics.2023; 79(1): 426.     CrossRef
• A comparative study of the policy response to COVID-19 in the ASEAN region: A dynamic simulated ARDL approach
  Nihal Ahmed, Dilawar Khan, Judit Oláh, József Popp, Stefan Cristian Gherghina
  PLOS ONE.2023; 18(1): e0276973.     CrossRef
• RNA Coronaviruses’ Outbreaks: Recent Progress on the SARS-CoV-2 Pandemic Diagnostic Tests, Vaccination and Therapeutics
  Ghadeer A.R.Y. Suaifan, Bayan A. Alkhawaja, Aya A.M. Mohammed
  Mini-Reviews in Medicinal Chemistry.2022; 22(4): 617.     CrossRef
• A computational tool for trend analysis and forecast of the COVID-19 pandemic
  Henrique Mohallem Paiva, Rubens Junqueira Magalhães Afonso, Fabiana Mara Scarpelli de Lima Alvarenga Caldeira, Ester de Andrade Velasquez
  Applied Soft Computing.2021; 105: 107289.     CrossRef
• Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges
  Jaime Castillo-León, Ramona Trebbien, John J. Castillo, Winnie E. Svendsen
  The Analyst.2021; 146(12): 3750.     CrossRef
• A network-based model to explore the role of testing in the epidemiological control of the COVID-19 pandemic
  Yapeng Cui, Shunjiang Ni, Shifei Shen
  BMC Infectious Diseases.2021;[Epub]     CrossRef
• Laboratory testing of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 (2019‐nCoV): Current status, challenges, and countermeasures
  Ying Yan, Le Chang, Lunan Wang
  Reviews in Medical Virology.2020;[Epub]     CrossRef
• Laboratory verification of an RT‐PCR assay for SARS‐CoV‐2
  Yingping Wu, Wei Xu, Zhiqiang Zhu, Xiaoping Xia
  Journal of Clinical Laboratory Analysis.2020;[Epub]     CrossRef
• Current diagnostic tools for coronaviruses–From laboratory diagnosis to POC diagnosis for COVID‐19
  Yung‐Chih Wang, Yi‐Tzu Lee, Ting Yang, Jun‐Ren Sun, Ching‐Fen Shen, Chao‐Min Cheng
  Bioengineering & Translational Medicine.2020;[Epub]     CrossRef
• The Molecular Diagnosis Protocols of New Coronavirus (COVID-19); Specificity and Sensitivity an Overview
  Abdullah Ahmed Hama, Othman Abdulrahman Mohammed, Fatima Mahmud Ali, Osama Hamid Shareef, Sardar Muhammad Wli, Sabiha Sharif, Syamand Ahmed Qadir
  Kurdistan Journal of Applied Research.2020; : 13.     CrossRef
• Thoughts on What Chemists Can Contribute to Fighting SARS‐CoV‐2 – A Short Note on Hand Sanitizers, Drug Candidates and Outreach
  Till Opatz, Joerg Senn‐Bilfinger, Clemens Richert
  Angewandte Chemie.2020; 132(24): 9320.     CrossRef
• Thoughts on What Chemists Can Contribute to Fighting SARS‐CoV‐2 – A Short Note on Hand Sanitizers, Drug Candidates and Outreach
  Till Opatz, Joerg Senn‐Bilfinger, Clemens Richert
  Angewandte Chemie International Edition.2020; 59(24): 9236.     CrossRef
• An updated roadmap for MERS-CoV research and product development: focus on diagnostics
  Cassandra Kelly-Cirino, Laura T Mazzola, Arlene Chua, Christopher J Oxenford, Maria D Van Kerkhove
  BMJ Global Health.2019; 4(Suppl 2): e001105.     CrossRef
• Development and validation of different indirect ELISAs for MERS-CoV serological testing
  Anwar M. Hashem, Sawsan S. Al-amri, Tagreed L. Al-subhi, Loai A. Siddiq, Ahmed M. Hassan, Maha M. Alawi, Rowa Y. Alhabbab, Salwa I. Hindawi, Osama B. Mohammed, Nabil S. Amor, Abdulaziz N. Alagaili, Ahmed A. Mirza, Esam I. Azhar
  Journal of Immunological Methods.2019; 466: 41.     CrossRef
• International Biological Reference Preparations for Epidemic Infectious Diseases
  Tommy Rampling, Mark Page, Peter Horby
  Emerging Infectious Diseases.2019; 25(2): 205.     CrossRef
• MERS coronavirus outbreak: Implications for emerging viral infections
  Awad Al-Omari, Ali A. Rabaan, Samer Salih, Jaffar A. Al-Tawfiq, Ziad A. Memish
  Diagnostic Microbiology and Infectious Disease.2019; 93(3): 265.     CrossRef
• Inclusion of MERS‐spike protein ELISA in algorithm to determine serologic evidence of MERS‐CoV infection
  Suvang Trivedi, Congrong Miao, Mohammad M. Al‐Abdallat, Aktham Haddadin, Sultan Alqasrawi, Ibrahim Iblan, Mohannad A. Nsour, Tarek Alsanouri, Sami S. Ali, Brian Rha, Susan I. Gerber, Daniel C. Payne, Azaibi Tamin, Natalie J. Thornburg
  Journal of Medical Virology.2018; 90(2): 367.     CrossRef
• The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab
  Malwina J. Radwańska, Mateusz Jaskółowski, Elena Davydova, Urszula Derewenda, Tsuyoshi Miyake, Daniel A. Engel, Anthony A. Kossiakoff, Zygmunt S. Derewenda
  Acta Crystallographica Section D Structural Biology.2018; 74(7): 681.     CrossRef
• MERS, SARS and other coronaviruses as causes of pneumonia
  Yudong Yin, Richard G. Wunderink
  Respirology.2018; 23(2): 130.     CrossRef
• Hydrogel Tethering Enhances Interdomain Stabilization of Single-Chain Antibodies
  Yijia Xiong, Nicole R. Ford, Karen A. Hecht, Guritno Roesijadi, Thomas C. Squier
  Bioconjugate Chemistry.2017; 28(11): 2804.     CrossRef
• An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus
  Ian Mackay, Katherine Arden
  Viruses.2017; 9(12): 369.     CrossRef

Citations

Citations to this article as recorded by  

• Current insights into human pathogenic phenuiviruses and the host immune system
  Chuan-Min Zhou, Ze-Zheng Jiang, Ning Liu, Xue-Jie Yu
  Virulence.2024;[Epub]     CrossRef
• Digoxin is a potent inhibitor of Bunyamwera virus infection in cell culture
  Beatriz Pacheco, Alberto Fernández-Oliva, Moisés García-Serradilla, Cristina Risco
  Journal of General Virology .2023;[Epub]     CrossRef
• Design and evaluation of neutralizing and fusion inhibitory peptides to Crimean-Congo hemorrhagic fever virus
  Megan C. Mears, Sergio E. Rodriguez, Katharina S. Schmitz, Angel Padilla, Sudipta Biswas, Maria N.B. Cajimat, Chad E. Mire, Stephen R. Welch, Éric Bergeron, Christopher A. Alabi, Matteo Porotto, Dennis A. Bente
  Antiviral Research.2022; 207: 105401.     CrossRef
• Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and development
  Megan A. Files, Clairissa A. Hansen, Vanessa C. Herrera, Craig Schindewolf, Alan D. T. Barrett, David W. C. Beasley, Nigel Bourne, Gregg N. Milligan
  npj Vaccines.2022;[Epub]     CrossRef
• Chloroquine, an Anti-Malaria Drug as Effective Prevention for Hantavirus Infections
  Valentijn Vergote, Lies Laenen, Raf Mols, Patrick Augustijns, Marc Van Ranst, Piet Maes
  Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
• Light and electron microscopy imaging unveils new aspects of the antiviral capacity of silver nanoparticles in bunyavirus-infected cells
  Moisés García-Serradilla, Cristina Risco
  Virus Research.2021; 302: 198444.     CrossRef
• Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection
  Mutsuyo Takayama-Ito, Masayuki Saijo
  Frontiers in Microbiology.2020;[Epub]     CrossRef
• Multimeric single-domain antibody complexes protect against bunyavirus infections
  Paul J Wichgers Schreur, Sandra van de Water, Michiel Harmsen, Erick Bermúdez-Méndez, Dubravka Drabek, Frank Grosveld, Kerstin Wernike, Martin Beer, Andrea Aebischer, Olalekan Daramola, Sara Rodriguez Conde, Karen Brennan, Dorota Kozub, Maiken Søndergaard
  eLife.2020;[Epub]     CrossRef
• Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys
  Robert W. Cross, Abhishek N. Prasad, Viktoriya Borisevich, Joan B. Geisbert, Krystle N. Agans, Daniel J. Deer, Karla A. Fenton, Thomas W. Geisbert, Waleed Saleh Al-Salem
  PLOS Neglected Tropical Diseases.2020; 14(8): e0008637.     CrossRef
• High Prevalence of a Newly Discovered Wutai Mosquito Phasivirus in Mosquitoes from Rio de Janeiro, Brazil
  Mário Sérgio Ribeiro, Tania Ayllón, Viviana Malirat, Daniel Cardoso Portela Câmara, Cristina Maria Giordano Dias, Guilherme Louzada, Davis Fernandes-Ferreira, Roberto de Andrade Medronho, Renata Campos Acevedo
  Insects.2019; 10(5): 135.     CrossRef
• Parallel Survey of Two Widespread Renal Syndrome-Causing Zoonoses:Leptospiraspp. andHantavirusin Urban Environment, Hungary
  Kornélia Kurucz, Mónika Madai, Dominika Bali, Dávid Hederics, Győző Horváth, Gábor Kemenesi, Ferenc Jakab
  Vector-Borne and Zoonotic Diseases.2018; 18(4): 200.     CrossRef
• A lethal disease model for New World hantaviruses using immunosuppressed Syrian hamsters
  Valentijn Vergote, Lies Laenen, Bert Vanmechelen, Marc Van Ranst, Erik Verbeken, Jay W. Hooper, Piet Maes, Michael R. Holbrook
  PLOS Neglected Tropical Diseases.2017; 11(10): e0006042.     CrossRef

Citations

Citations to this article as recorded by  

• Detection and characterization of highly pathogenic avian influenza A (H5N1) clade 2.3.4.4b virus circulating in Argentina in 2023
  María Carolina Artuso, Vanina Daniela Marchione, Estefanía Benedetti, Paula Bonastre, Ana María Alvarez, Luana Piccini, Angeles Ponde, Evelyn Barrios Benito, Marcos Fabeiro, Karen Waisman, Luciano Coppola, Tomás Poklepovich, Ariana Chamorro, Martín Avaro,
  Revista Argentina de Microbiología.2024;[Epub]     CrossRef
• Simultaneous Differential Detection of H5, H7, H9 and Nine NA Subtypes of Avian Influenza Viruses via a GeXP Assay
  Sisi Luo, Zhixun Xie, Meng Li, Dan Li, Minxiu Zhang, Zhihua Ruan, Liji Xie, Sheng Wang, Qing Fan, Yanfang Zhang, Jiaoling Huang, Tingting Zeng
  Microorganisms.2024; 12(1): 143.     CrossRef
• Multivalent next generation influenza virus vaccines protect against seasonal and pre-pandemic viruses
  Naoko Uno, Ted M. Ross
  Scientific Reports.2024;[Epub]     CrossRef
• Recent Occurrence, Diversity, and Candidate Vaccine Virus Selection for Pandemic H5N1: Alert Is in the Air
  Yordanka Medina-Armenteros, Daniela Cajado-Carvalho, Ricardo das Neves Oliveira, Milena Apetito Akamatsu, Paulo Lee Ho
  Vaccines.2024; 12(9): 1044.     CrossRef
• Pigs are highly susceptible to but do not transmit mink-derived highly pathogenic avian influenza virus H5N1 clade 2.3.4.4b
  Taeyong Kwon, Jessie D. Trujillo, Mariano Carossino, Eu Lim Lyoo, Chester D. McDowell, Konner Cool, Franco S. Matias-Ferreyra, Trushar Jeevan, Igor Morozov, Natasha N. Gaudreault, Udeni B.R. Balasuriya, Richard J. Webby, Nikolaus Osterrieder, Juergen A. R
  Emerging Microbes & Infections.2024;[Epub]     CrossRef
• Transmission dynamics of highly pathogenic avian influenza virus at the wildlife-poultry-environmental interface: A case study
  Jolene A. Giacinti, Madeline Jarvis-Cross, Hannah Lewis, Jennifer F. Provencher, Yohannes Berhane, Kevin Kuchinski, Claire M. Jardine, Anthony Signore, Sarah C. Mansour, Denby E. Sadler, Brian Stevens, Natalie A. Prystajecky, Sailendra N. Sarma, Davor Ojk
  One Health.2024; 19: 100932.     CrossRef
• On-Site and Visual Detection of the H5 Subtype Avian Influenza Virus Based on RT-RPA and CRISPR/Cas12a
  Xu Zhou, Siwen Wang, Yue Ma, Yongping Jiang, Yanbing Li, Jianzhong Shi, Guohua Deng, Guobin Tian, Huihui Kong, Xiurong Wang
  Viruses.2024; 16(5): 753.     CrossRef
• First Case of Highly Pathogenic Avian Influenza H5N1 in Montenegro
  Bojan Adzic, Sejla Goletic, Nikola Pejoviс, Andrej Vizi, Nikita Yolshin
  Acta Veterinaria.2024; 74(1): 145.     CrossRef
• Self-Assembling Nanoparticle Hemagglutinin Influenza Vaccines Induce High Antibody Response
  Hongying Ren, Bin Zhang, Xinwei Zhang, Tiantian Wang, Xvchen Hou, Xianyong Lan, Chuanying Pan, Jun Wu, Bo Liu
  International Journal of Molecular Sciences.2024; 25(13): 7259.     CrossRef
• Highly pathogenic avian influenza A (H5N1) in marine mammals and seabirds in Peru
  Mariana Leguia, Alejandra Garcia-Glaessner, Breno Muñoz-Saavedra, Diana Juarez, Patricia Barrera, Carlos Calvo-Mac, Javier Jara, Walter Silva, Karl Ploog, Lady Amaro, Paulo Colchao-Claux, Christine K. Johnson, Marcela M. Uhart, Martha I. Nelson, Jesus Les
  Nature Communications.2023;[Epub]     CrossRef
• Global review of the H5N8 avian influenza virus subtype
  Saba Rafique, Farooq Rashid, Sajda Mushtaq, Akbar Ali, Meng Li, Sisi Luo, Liji Xie, Zhixun Xie
  Frontiers in Microbiology.2023;[Epub]     CrossRef
• Development and Validation of Competitive ELISA for Detection of H5 Hemagglutinin Antibodies
  Orie Hochman, Wanhong Xu, Ming Yang, Chengbo Yang, Aruna Ambagala, Anna Rogiewicz, Joseph J. Wang, Yohannes Berhane
  Poultry.2023; 2(3): 349.     CrossRef
• Global dissemination of H5N1 influenza viruses bearing the clade 2.3.4.4b HA gene and biologic analysis of the ones detected in China
  Pengfei Cui, Jianzhong Shi, Congcong Wang, Yuancheng Zhang, Xin Xing, Huihui Kong, Cheng Yan, Xianying Zeng, Liling Liu, Guobin Tian, Chengjun Li, Guohua Deng, Hualan Chen
  Emerging Microbes & Infections.2022; 11(1): 1693.     CrossRef
• Improved Subtyping of Avian Influenza Viruses Using an RT-qPCR-Based Low Density Array: ‘Riems Influenza a Typing Array’, Version 2 (RITA-2)
  Kareem E. Hassan, Ann Kathrin Ahrens, Ahmed Ali, Magdy F. El-Kady, Hafez M. Hafez, Thomas C. Mettenleiter, Martin Beer, Timm Harder
  Viruses.2022; 14(2): 415.     CrossRef
• Genetic evolution of hemagglutinin and neuraminidase genes of H5N1 highly pathogenic avian influenza viruses in Thailand
  Pirom Noisumdaeng, Juthamas Phadungsombat, Sasrinakarn Weerated, Witthawat Wiriyarat, Pilaipan Puthavathana
  PeerJ.2022; 10: e14419.     CrossRef
• H5N1 infection impairs the alveolar epithelial barrier through intercellular junction proteins via Itch-mediated proteasomal degradation
  Tao Ruan, Yuling Sun, Jingting Zhang, Jing Sun, Wei Liu, Richard A. Prinz, Daxin Peng, Xiufan Liu, Xiulong Xu
  Communications Biology.2022;[Epub]     CrossRef
• Genetic and biological characteristics of the globally circulating H5N8 avian influenza viruses and the protective efficacy offered by the poultry vaccine currently used in China
  Pengfei Cui, Xianying Zeng, Xuyong Li, Yanbing Li, Jianzhong Shi, Conghui Zhao, Zhiyuan Qu, Yanwen Wang, Jing Guo, Wenli Gu, Qi Ma, Yuancheng Zhang, Weipeng Lin, Minghui Li, Jingman Tian, Dongxue Wang, Xin Xing, Yanjing Liu, Shuxin Pan, Yaping Zhang, Hong
  Science China Life Sciences.2022; 65(4): 795.     CrossRef
• A broad spectrum HVT-H5 avian influenza vector vaccine which induces a rapid onset of immunity
  Sylvia Reemers, Iwan Verstegen, Stephanie Basten, Willem Hubers, Saskia van de Zande
  Vaccine.2021; 39(7): 1072.     CrossRef
• The genetics of highly pathogenic avian influenza viruses of subtype H5 in Germany, 2006–2020
  Jacqueline King, Timm Harder, Franz J. Conraths, Martin Beer, Anne Pohlmann
  Transboundary and Emerging Diseases.2021; 68(3): 1136.     CrossRef
• Safety, Immunogenicity, and Protective Efficacy of an H5N1 Chimeric Cold-Adapted Attenuated Virus Vaccine in a Mouse Model
  Weiyang Sun, Zhenfei Wang, Yue Sun, Dongxu Li, Menghan Zhu, Menglin Zhao, Yutian Wang, Jiaqi Xu, Yunyi Kong, Yuanguo Li, Na Feng, Tiecheng Wang, Yongkun Zhao, Songtao Yang, Yuwei Gao, Xianzhu Xia
  Viruses.2021; 13(12): 2420.     CrossRef
• Development and biochemical characterization of the monoclonal antibodies for specific detection of the emerging H5N8 and H5Nx avian influenza virus hemagglutinins
  Yu-Chen Cheng, Shih-Chung Chang
  Applied Microbiology and Biotechnology.2021; 105(1): 235.     CrossRef
• Different Sensitivity of Japanese Native-Bred Chickens to H5 Subtypes of Highly Pathogenic Avian Influenza Viruses
  Aya Matsuu, Taichiro Tanikawa, Yoshikazu Fujimoto, Mihoko Yabuki, Ryota Tsunekuni, Saki Sakuma, Yuko Uchida, Takehiko Saito
  Avian Diseases.2021;[Epub]     CrossRef
• Development of an antigen-ELISA and a colloidal gold–based immunochromatographic strip based on monoclonal antibodies for detection of avian influenza A(H5) viruses
  Yixin Xiao, Fan Yang, Fumin Liu, Linfang Cheng, Hangping Yao, Nanping Wu, Haibo Wu
  Journal of Veterinary Diagnostic Investigation.2021; 33(5): 969.     CrossRef
• N-linked glycosylation at site 158 of the HA protein of H5N6 highly pathogenic avian influenza virus is important for viral biological properties and host immune responses
  Ruyi Gao, Min Gu, Liwei Shi, Kaituo Liu, Xiuli Li, Xiaoquan Wang, Jiao Hu, Xiaowen Liu, Shunlin Hu, Sujuan Chen, Daxin Peng, Xinan Jiao, Xiufan Liu
  Veterinary Research.2021;[Epub]     CrossRef
• Wild bird trade at live poultry markets potentiates risks of avian influenza virus introduction in Iran
  Amir Modirihamedan, Shabnam Aghajantabar, Jacqueline King, Annika Graaf, Anne Pohlmann, Leila Aghaiyan, Zahra Ziafati Kafi, Yeganeh Mahfoozi, Hossein Hosseini, Martin Beer, Arash Ghalyanchilangeroudi, Timm Harder
  Infection Ecology & Epidemiology.2021;[Epub]     CrossRef
• A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies
  Adrian Creanga, Rebecca A. Gillespie, Brian E. Fisher, Sarah F. Andrews, Julia Lederhofer, Christina Yap, Liam Hatch, Tyler Stephens, Yaroslav Tsybovsky, Michelle C. Crank, Julie E. Ledgerwood, Adrian B. McDermott, John R. Mascola, Barney S. Graham, Masar
  Nature Communications.2021;[Epub]     CrossRef
• Outbreak Severity of Highly Pathogenic Avian Influenza A(H5N8) Viruses Is Inversely Correlated to Polymerase Complex Activity and Interferon Induction
  René M. Vigeveno, Marjolein J. Poen, Edyth Parker, Melle Holwerda, Karen de Haan, Thijs van Montfort, Nicola S. Lewis, Colin A. Russell, Ron A. M. Fouchier, Menno D. de Jong, Dirk Eggink, Stacey Schultz-Cherry
  Journal of Virology.2020;[Epub]     CrossRef
• Certainty of success: three critical parameters in coronavirus vaccine development
  David C. Kaslow
  npj Vaccines.2020;[Epub]     CrossRef
• Transmission experiments support clade-level differences in the transmission and pathogenicity of Cambodian influenza A/H5N1 viruses
  Paul F. Horwood, Thomas Fabrizio, Srey Viseth Horm, Artem Metlin, Sopheaktra Ros, Songha Tok, Trushar Jeevan, Patrick Seiler, Phalla Y, Sareth Rith, Annika Suttie, Philippe Buchy, Erik A. Karlsson, Richard Webby, Philippe Dussart
  Emerging Microbes & Infections.2020; 9(1): 1702.     CrossRef
• Effects and safety of Tanreqing injection on viral pneumonia: Retraction
  Yue Qiu, Xue Pan, Lin Su, Hui Lui, Ya-Dong Li
  Medicine.2020; 99(37): e22022.     CrossRef
• A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge
  Edris Shirvani, Berin P. Varghese, Anandan Paldurai, Siba K. Samal
  Scientific Reports.2020;[Epub]     CrossRef
• Sequential DNA immunization of chickens with bivalent heterologous vaccines induce highly reactive and cross-specific antibodies against influenza hemagglutinin
  Anna Stachyra, Anna Góra-Sochacka, Jan P Radomski, Agnieszka Sirko
  Poultry Science.2019; 98(1): 199.     CrossRef
• A review of H5Nx avian influenza viruses
  Ivette A. Nuñez, Ted M. Ross
  Therapeutic Advances in Vaccines and Immunotherapy.2019;[Epub]     CrossRef
• Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge
  Su He Wang, Douglas Smith, Zhengyi Cao, Jesse Chen, Hugo Acosta, Jessica A. Chichester, Vidadi Yusibov, Stephen J. Streatfield, Ali Fattom, James R. Baker
  Vaccine.2019; 37(12): 1591.     CrossRef
• The safety and immunogenicity of a cell-derived adjuvanted H5N1 vaccine – A phase I randomized clinical trial
  Aristine Cheng, Szu-Min Hsieh, Sung-Ching Pan, Yu-Han Li, Erh-Fang Hsieh, Hsiang-Chi Lee, Ting-Wan Lin, Kuan-Lang Lai, Charles Chen, Stanley Shi-Chung Chang, Shan-Chwen Chang
  Journal of Microbiology, Immunology and Infection.2019; 52(5): 685.     CrossRef
• Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge
  Irina Isakova-Sivak, Victoria Matyushenko, Tatiana Kotomina, Irina Kiseleva, Elena Krutikova, Svetlana Donina, Andrey Rekstin, Natalia Larionova, Daria Mezhenskaya, Konstantin Sivak, Arman Muzhikyan, Anastasia Katelnikova, Larisa Rudenko
  Vaccines.2019; 7(3): 61.     CrossRef
• Sensitivity of Commercially Available Influenza Rapid Diagnostic Tests in the 2018–2019 Influenza Season
  Yuko Sakai-Tagawa, Seiya Yamayoshi, Yoshihiro Kawaoka
  Frontiers in Microbiology.2019;[Epub]     CrossRef
• Adaptive Evolution of Human-Isolated H5Nx Avian Influenza A Viruses
  Fucheng Guo, Yiliang Li, Shu Yu, Lu Liu, Tingting Luo, Zhiqing Pu, Dan Xiang, Xuejuan Shen, David M. Irwin, Ming Liao, Yongyi Shen
  Frontiers in Microbiology.2019;[Epub]     CrossRef
• DDX5 RNA Helicases: Emerging Roles in Viral Infection
  Wenyu Cheng, Guohua Chen, Huaijie Jia, Xiaobing He, Zhizhong Jing
  International Journal of Molecular Sciences.2018; 19(4): 1122.     CrossRef
• Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge
  Raffael Nachbagauer, David Shore, Hua Yang, Scott K. Johnson, Jon D. Gabbard, S. Mark Tompkins, Jens Wrammert, Patrick C. Wilson, James Stevens, Rafi Ahmed, Florian Krammer, Ali H. Ellebedy, Stacey Schultz-Cherry
  Journal of Virology.2018;[Epub]     CrossRef
• Advances in Influenza Virus Research: A Personal Perspective
  Kanta Subbarao
  Viruses.2018; 10(12): 724.     CrossRef
• Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure
  Sung J. Yoo, Taeyong Kwon, Young S. Lyoo
  Clinical and Experimental Vaccine Research.2018; 7(1): 1.     CrossRef
• Characterization of H5N1 Influenza Virus Quasispecies with Adaptive Hemagglutinin Mutations from Single-Virus Infections of Human Airway Cells
  Yohei Watanabe, Yasuha Arai, Norihito Kawashita, Madiha S. Ibrahim, Emad M. Elgendy, Tomo Daidoji, Junichi Kajikawa, Hiroaki Hiramatsu, Nongluk Sriwilaijaroen, Takao Ono, Tatsuya Takagi, Kazuo Takahashi, Tatsuo Shioda, Kazuhiko Matsumoto, Yasuo Suzuki, Ta
  Journal of Virology.2018;[Epub]     CrossRef
• A 113-amino-acid truncation at the NS1 C-terminus is a determinant for viral replication of H5N6 avian influenza virus in vitro and in vivo
  Xiaole Cui, Yanhong Ji, Zhengxiang Wang, Yingying Du, Haoran Guo, Liang Wang, Hualan Chen, Qiyun Zhu
  Veterinary Microbiology.2018; 225: 6.     CrossRef
• Enhanced Human-Type Receptor Binding by Ferret-Transmissible H5N1 with a K193T Mutation
  Wenjie Peng, Kim M. Bouwman, Ryan McBride, Oliver C. Grant, Robert J. Woods, Monique H. Verheije, James C. Paulson, Robert P. de Vries, Adolfo García-Sastre
  Journal of Virology.2018;[Epub]     CrossRef
• Reactivity and sensitivity of commercially available influenza rapid diagnostic tests in Japan
  Yuko Sakai-Tagawa, Seiya Yamayoshi, Chiharu Kawakami, Mai Q. Le, Yuko Uchida, Takehiko Saito, Chairul A. Nidom, Ira Humaira, Kathy Toohey-Kurth, Abdel-Satar Arafa, Ming-Tsan Liu, Yuelong Shu, Yoshihiro Kawaoka
  Scientific Reports.2017;[Epub]     CrossRef
• Natural Reassortants of Potentially Zoonotic Avian Influenza Viruses H5N1 and H9N2 from Egypt Display Distinct Pathogenic Phenotypes in Experimentally Infected Chickens and Ferrets
  Mahmoud M. Naguib, Reiner Ulrich, Elisa Kasbohm, Christine L. P. Eng, Donata Hoffmann, Christian Grund, Martin Beer, Timm C. Harder, Adolfo García-Sastre
  Journal of Virology.2017;[Epub]     CrossRef
• Five distinct reassortants of H5N6 highly pathogenic avian influenza A viruses affected Japan during the winter of 2016–2017
  Nobuhiro Takemae, Ryota Tsunekuni, Kirill Sharshov, Taichiro Tanikawa, Yuko Uchida, Hiroshi Ito, Kosuke Soda, Tatsufumi Usui, Ivan Sobolev, Alexander Shestopalov, Tsuyoshi Yamaguchi, Junki Mine, Toshihiro Ito, Takehiko Saito
  Virology.2017; 512: 8.     CrossRef
• Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine
  Amy Lingel, Brianna L. Bullard, Eric A. Weaver
  Scientific Reports.2017;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Comparison of Five Serological Methods for the Detection of West Nile Virus Antibodies
  Philipp Girl, Kathrin Euringer, Mircea Coroian, Andrei Daniel Mihalca, Johannes P. Borde, Gerhard Dobler
  Viruses.2024; 16(5): 788.     CrossRef
• Exploring Zika Virus Impact on Endothelial Permeability: Insights into Transcytosis Mechanisms and Vascular Leakage
  Dama Faniriantsoa Henrio Marcellin, Jufang Huang
  Viruses.2024; 16(4): 629.     CrossRef
• Optimal control problem for mathematical modeling of Zika virus transmission using fractional order derivatives
  Abdelfatah Kouidere, Amine El Bhih, Issam Minifi, Omar Balatif, Khalid Adnaoui
  Frontiers in Applied Mathematics and Statistics.2024;[Epub]     CrossRef
• Analysis of RNA virus pathogenicity and development of novel prevention methods.
  Ryuta URAKI
  Uirusu.2024; 74(1): 57.     CrossRef
• Differences in the Membrane-Binding Properties of Flaviviral Nonstructural 1 (NS1) Protein: Comparative Simulations of Zika and Dengue Virus NS1 Proteins in Explicit Bilayers
  Rajagopalan Muthukumaran, Ramasubbu Sankararamakrishnan
  ACS Bio & Med Chem Au.2024; 4(3): 137.     CrossRef
• Bovine serum albumin nanoparticles containing Poly (I:C) can enhance the neutralizing antibody response induced by envelope protein of Orthoflavivirus zikaense
  Raíne Piva-Amaral, Gabriel Augusto Pires de Souza, João Carlos Vilela Vieira Júnior, Renato Fróes Goulart de Castro, William Permagnani Gozzi, Sergio Pereira Lima Neto, Ana Luisa Cauvilla dos Santos, Helena Pavani Cassiano, Lorena Christine Ferreira da Si
  International Immunopharmacology.2024; 128: 111523.     CrossRef
• Employing Machine Learning-Based QSAR for Targeting Zika Virus NS3 Protease: Molecular Insights and Inhibitor Discovery
  Hisham N. Altayb, Hanan Ali Alatawi
  Pharmaceuticals.2024; 17(8): 1067.     CrossRef
• Mice as an Animal Model for Japanese Encephalitis Virus Research: Mouse Susceptibility, Infection Route, and Viral Pathogenesis
  Jordan C. Frank, Byung-Hak Song, Young-Min Lee
  Pathogens.2023; 12(5): 715.     CrossRef
• Zika Virus: A Comprehensive Review
  Snehal Dilip Kothavale, Rinaj Rasul Attar, S. K. Mohite, Sagar B. Patil
  Research Journal of Pharmacology and Pharmacodynamics.2023; : 24.     CrossRef
• The Antiviral Potential of AdipoRon, an Adiponectin Receptor Agonist, Reveals the Ability of Zika Virus to Deregulate Adiponectin Receptor Expression
  Daed El Safadi, Grégorie Lebeau, Jonathan Turpin, Christian Lefebvre d’Hellencourt, Nicolas Diotel, Wildriss Viranaicken, Pascale Krejbich-Trotot
  Viruses.2023; 16(1): 24.     CrossRef
• Synthesis of copaiba (Copaifera officinalis) oil nanoemulsion and the potential against Zika virus: An in vitro study
  Tamara Carvalho, Marcela Guimarães Landim, Maria Letícia Duarte Lima, Cíntia Bittar, Beatriz Carvalho de Araújo Oliveira Faria, Paula Rahal, Milena Campelo Freitas de Lima, Valdir Florêncio da Veiga Junior, Graziella Anselmo Joanitti, Marilia Freitas Calm
  PLOS ONE.2023; 18(9): e0283817.     CrossRef
• Epidemiological evidence of acute transmission of Zika virus infection in dengue suspected patients in Sri-Lanka
  Mya Myat Ngwe Tun, Sandra Kendra Raini, Lakkumar Fernando, YINS Gunawardene, Shingo Inoue, Yuki Takamatsu, Takeshi Urano, Rohitha Muthugala, Menaka Hapugoda, Kouichi Morita
  Journal of Infection and Public Health.2023; 16(9): 1435.     CrossRef
• The Drosophila melanogaster prophenoloxidase system participates in immunity against Zika virus infection
  Ghada Tafesh‐Edwards, Ioannis Eleftherianos
  European Journal of Immunology.2023;[Epub]     CrossRef
• Designing photoaffinity tool compounds for the investigation of the DENV NS2B–NS3 protease allosteric binding pocket
  Hannah Maus, Andrea Gellert, Olivia R. Englert, Jia-Xuan Chen, Tanja Schirmeister, Fabian Barthels
  RSC Medicinal Chemistry.2023; 14(11): 2365.     CrossRef
• Quinazolinone Compounds Have Potent Antiviral Activity against Zika and Dengue Virus
  Md Ashraf-Uz-Zaman, Xin Li, Yuan Yao, Chandra Bhushan Mishra, Bala Krishna Moku, Yongcheng Song
  Journal of Medicinal Chemistry.2023; 66(15): 10746.     CrossRef
• Reprogramming of red blood cell metabolism in Zika virus–infected donors
  Alexis Catala, Mars Stone, Michael P. Busch, Angelo D'Alessandro
  Transfusion.2022; 62(5): 1045.     CrossRef
• Structure-based design of a novel inhibitor of the ZIKA virus NS2B/NS3 protease
  Yanchao Xiong, Fei Cheng, Junyi Zhang, Haixia Su, Hangchen Hu, Yi Zou, Minjun Li, Yechun Xu
  Bioorganic Chemistry.2022; 128: 106109.     CrossRef
• Host Molecules Regulating Neural Invasion of Zika Virus and Drug Repurposing Strategy
  Li Yin Tan, Thamil Vaani Komarasamy, William James, Vinod R. M. T. Balasubramaniam
  Frontiers in Microbiology.2022;[Epub]     CrossRef
• Functional Loop Dynamics and Characterization of the Inactive State of the NS2B-NS3 Dengue Protease due to Allosteric Inhibitor Binding
  Nisha Amarnath Jonniya, Parimal Kar
  Journal of Chemical Information and Modeling.2022; 62(16): 3800.     CrossRef
• Pandemic influenza A (H1N1) virus causes abortive infection of primary human T cells
  Jiapei Yu, Hui Li, Ju Jia, Zhisheng Huang, Shuai Liu, Ying Zheng, Shengrui Mu, Xiaoyan Deng, Xiaohui Zou, Yeming Wang, Xiao Shang, Dan Cui, Lixue Huang, Xiaoxuan Feng, William J. Liu, Bin Cao
  Emerging Microbes & Infections.2022; 11(1): 1191.     CrossRef
• Development and characterization of type I interferon receptor knockout sheep: A model for viral immunology and reproductive signaling
  Christopher J. Davies, Zhiqiang Fan, Kira P. Morgado, Ying Liu, Misha Regouski, Qinggang Meng, Aaron J. Thomas, Sang-Im Yun, Byung-Hak Song, Jordan C. Frank, Iuri V. Perisse, Arnaud Van Wettere, Young-Min Lee, Irina A. Polejaeva
  Frontiers in Genetics.2022;[Epub]     CrossRef
• β-Catenin Restricts Zika Virus Internalization by Downregulating Axl
  Oscar A. Jimenez, Srinivas D. Narasipura, Hannah J. Barbian, Yasmeen A. Albalawi, Melanie S. Seaton, KaReisha F. Robinson, Lena Al-Harthi, Susana López
  Journal of Virology.2021;[Epub]     CrossRef
• Zika virus endemic challenges during COVID-19 pandemic in Africa
  Abdullahi Tunde Aborode, Mahnoor Sukaina, Harendra Kumar, Tahreem Farooqui, Samar Faheem, Priyanka Chahal, Luay Alkazmi, Helal F. Hetta, Gaber El-Saber Batiha
  Tropical Medicine and Health.2021;[Epub]     CrossRef
• Deciphering the Role of Extracellular Vesicles Derived from ZIKV-Infected hcMEC/D3 Cells on the Blood–Brain Barrier System
  Antonios Fikatas, Jonas Dehairs, Sam Noppen, Jordi Doijen, Frank Vanderhoydonc, Eef Meyen, Johannes V. Swinnen, Christophe Pannecouque, Dominique Schols
  Viruses.2021; 13(12): 2363.     CrossRef
• Nanoparticles as Vaccines to Prevent Arbovirus Infection: A Long Road Ahead
  Gabriel Augusto Pires de Souza, Raíssa Prado Rocha, Ricardo Lemes Gonçalves, Cyntia Silva Ferreira, Breno de Mello Silva, Renato Fróes Goulart de Castro, João Francisco Vitório Rodrigues, João Carlos Vilela Vieira Júnior, Luiz Cosme Cotta Malaquias, Jônat
  Pathogens.2021; 10(1): 36.     CrossRef
• Operationalizing Culturally Responsive Research Practices: Documenting the Communication Skills of Children With Confirmed or Possible Exposure to the Zika Virus in Saint Lucia, West Indies
  Keisha T. Lindsay Nurse, Kim Gardner, Maria R. Brea
  Perspectives of the ASHA Special Interest Groups.2021; 6(1): 191.     CrossRef
• Synthesis, Structure–Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B–NS3 Protease
  Shenyou Nie, Yuan Yao, Fangrui Wu, Xiaowei Wu, Jidong Zhao, Yuanda Hua, Jingyu Wu, Tong Huo, Yi-Lun Lin, Alexander R. Kneubehl, Megan B. Vogt, Josephine Ferreon, Rebecca Rico-Hesse, Yongcheng Song
  Journal of Medicinal Chemistry.2021; 64(5): 2777.     CrossRef
• Zika virus lateral flow assays using reverse transcription-loop-mediated isothermal amplification
  Gna Ahn, SeonHyung Lee, Se Hee Lee, Yun Hee Baek, Min-Suk Song, Yang-Hoon Kim, Ji-Young Ahn
  RSC Advances.2021; 11(29): 17800.     CrossRef
• CRISPR Tackles Emerging Viral Pathogens
  Emily N. Kirby, Byron Shue, Paul Q. Thomas, Michael R. Beard
  Viruses.2021; 13(11): 2157.     CrossRef
• Relationship between vertical stratification and feeding habits of mosquito (Diptera: Culicidae) assemblages collected in conservation units in the green belt of the city of São Paulo, Brazil
  Eduardo Evangelista, Antônio Ralph Medeiros-Sousa, Walter Ceretti-Junior, Rafael Oliveira-Christe, Ramon Wilk-da-Silva, Ana Maria Ribeiro de Castro Duarte, Daniel Pagotto Vendrami, Gabriela Cristina de Carvalho, Luis Filipe Mucci, Mauro Toledo Marrelli
  Acta Tropica.2021; 221: 106009.     CrossRef
• The Geraniin-Rich Extract from Reunion Island Endemic Medicinal Plant Phyllanthus phillyreifolius Inhibits Zika and Dengue Virus Infection at Non-Toxic Effect Doses in Zebrafish
  Juliano G. Haddad, Dovilė Grauzdytė, Andrea Cristine Koishi, Wildriss Viranaicken, Petras Rimantas Venskutonis, Claudia Nunes Duarte dos Santos, Philippe Desprès, Nicolas Diotel, Chaker El Kalamouni
  Molecules.2020; 25(10): 2316.     CrossRef
• Development, Characterization, and Application of Two Reporter-Expressing Recombinant Zika Viruses
  Sang-Im Yun, Byung-Hak Song, Michael E. Woolley, Jordan C. Frank, Justin G. Julander, Young-Min Lee
  Viruses.2020; 12(5): 572.     CrossRef
• Field-deployable molecular diagnostic platform for arbovirus detection in Aedes aegypti
  Natalie Rutkowski, Yuemei Dong, George Dimopoulos
  Parasites & Vectors.2020;[Epub]     CrossRef
• The Molecular Interactions of ZIKV and DENV with the Type-I IFN Response
  Rosa C. Coldbeck-Shackley, Nicholas S. Eyre, Michael R. Beard
  Vaccines.2020; 8(3): 530.     CrossRef
• Detection of Zika and dengue viruses in wild-caught mosquitoes collected during field surveillance in an environmental protection area in São Paulo, Brazil
  Karolina Morales Barrio-Nuevo, Mariana Sequetin Cunha, Adriana Luchs, Aristides Fernandes, Iray Maria Rocco, Luis Filipe Mucci, Renato Pereira de Souza, Antônio Ralph Medeiros-Sousa, Walter Ceretti-Junior, Mauro Toledo Marrelli, Humberto Lanz-Mendoza
  PLOS ONE.2020; 15(10): e0227239.     CrossRef
• Future and Perspectives of the Zika Virus: Drug Repurposing as a Powerful Tool for Treatment Insights
  Denise Rampini, Diego Campos Prieto, Ana Luisa Colzi, Renan Vinícius de Araújo, Jeanine Giarolla
  Mini-Reviews in Medicinal Chemistry.2020; 20(18): 1917.     CrossRef
• An in silico integrative protocol for identifying key genes and pathways useful to understand emerging virus disease pathogenesis
  Gabriel Augusto Pires de Souza, Ezequiel Aparecido Salvador, Fernanda Roza de Oliveira, Luiz Cosme Cotta Malaquias, Jonatas Santos Abrahão, Luiz Felipe Leomil Coelho
  Virus Research.2020; 284: 197986.     CrossRef
• Development of oncolytic virotherapy: from genetic modification to combination therapy
  Qiaoshuai Lan, Shuai Xia, Qian Wang, Wei Xu, Haiyan Huang, Shibo Jiang, Lu Lu
  Frontiers of Medicine.2020; 14(2): 160.     CrossRef
• Anti-Zika virus activity and chemical characterization by ultra-high performance liquid chromatography (UPLC-DAD-UV-MS) of ethanol extracts in Tecoma species
  Adriana Cotta Cardoso Reis, Breno Mello Silva, Hélia Maria Marques de Moura, Guilherme Rocha Pereira, Geraldo Célio Brandão
  BMC Complementary Medicine and Therapies.2020;[Epub]     CrossRef
• Applying a pan-flavivirus RT-qPCR assay in Brazilian public health surveillance
  Mariana Sequetin Cunha, Adriana Luchs, Fabiana Cristina Pereira dos Santos, Giovana Santos Caleiro, Maurício Lacerda Nogueira, Paulo César Maiorka
  Archives of Virology.2020; 165(8): 1863.     CrossRef
• The range of sampling times affects Zika virus evolutionary rates and divergence times
  Lucia P. Barzilai, Carlos G. Schrago
  Archives of Virology.2019; 164(12): 3027.     CrossRef
• Prevalence of Zika virus in blood donations: a systematic review and meta-analysis
  Rongfei Liu, Xuanzhuo Wang, Yu Ma, Jianyong Wu, Chen Mao, Lihong Yuan, Jiahai Lu
  BMC Infectious Diseases.2019;[Epub]     CrossRef
• Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease
  Yuan Yao, Tong Huo, Yi-Lun Lin, Shenyou Nie, Fangrui Wu, Yuanda Hua, Jingyu Wu, Alexander R. Kneubehl, Megan B. Vogt, Rebecca Rico-Hesse, Yongcheng Song
  Journal of the American Chemical Society.2019; 141(17): 6832.     CrossRef
• Molecular epidemiology of dengue, yellow fever, Zika and Chikungunya arboviruses: An update
  Adriana Higuera, Juan David Ramírez
  Acta Tropica.2019; 190: 99.     CrossRef
• Crystallographic Snapshots of the Zika Virus NS3 Helicase Help Visualize the Reactant Water Replenishment
  Junnan Fang, Xuping Jing, Guoliang Lu, Yi Xu, Peng Gong
  ACS Infectious Diseases.2019; 5(2): 177.     CrossRef
• Zika Fever: Development of Diagnostics, Prevention and Treatment
  E. I. Kazachinskaya, D. V. Shan’shin, A. V. Ivanova
  Problems of Particularly Dangerous Infections.2019; (2): 6.     CrossRef
• Selective Disruption of the Blood–Brain Barrier by Zika Virus
  Ana Rachel Leda, Luc Bertrand, Ibolya Edit Andras, Nazira El-Hage, Madhavan Nair, Michal Toborek
  Frontiers in Microbiology.2019;[Epub]     CrossRef
• Vδ2 T-Cells Kill ZIKV-Infected Cells by NKG2D-Mediated Cytotoxicity
  Eleonora Cimini, Alessandra Sacchi, Sara De Minicis, Veronica Bordoni, Rita Casetti, Germana Grassi, Francesca Colavita, Concetta Castilletti, Maria Rosaria Capobianchi, Giuseppe Ippolito, Maria Giovanna Desimio, Margherita Doria, Chiara Agrati
  Microorganisms.2019; 7(9): 350.     CrossRef
• Distinctive regulatory properties of pyruvate kinase 1 from Aedes aegypti mosquitoes
  Natthida Petchampai, Claribel Murillo-Solano, Jun Isoe, Juan C. Pizarro, Patricia Y. Scaraffia
  Insect Biochemistry and Molecular Biology.2019; 104: 82.     CrossRef
• Rational Control of Poliovirus RNA-Dependent RNA Polymerase Fidelity by Modulating Motif-D Loop Conformational Dynamics
  Jingjing Shi, Jacob M. Perryman, Xiaorong Yang, Xinran Liu, Derek M. Musser, Alyson K. Boehr, Ibrahim M. Moustafa, Jamie J. Arnold, Craig E. Cameron, David D. Boehr
  Biochemistry.2019; 58(36): 3735.     CrossRef
• Model System for the Formation of Tick-Borne Encephalitis Virus Replication Compartments without Viral RNA Replication
  Wai-Lok Yau, Van Nguyen-Dinh, Elin Larsson, Richard Lindqvist, Anna K. Överby, Richard Lundmark, Julie K. Pfeiffer
  Journal of Virology.2019;[Epub]     CrossRef
• Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
  Marc Desforges, Alain Le Coupanec, Philippe Dubeau, Andréanne Bourgouin, Louise Lajoie, Mathieu Dubé, Pierre J. Talbot
  Viruses.2019; 12(1): 14.     CrossRef
• Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models
  Penghui Li, Xianliang Ke, Ting Wang, Zhongyuan Tan, Dan Luo, Yuanjiu Miao, Jianhong Sun, Yuan Zhang, Yan Liu, Qinxue Hu, Fuqiang Xu, Hanzhong Wang, Zhenhua Zheng, Julie K. Pfeiffer
  Journal of Virology.2018;[Epub]     CrossRef
• The Recent Epidemic Spread of Zika Virus Disease
  Chang-Kweng Lim
  Uirusu.2018; 68(1): 1.     CrossRef
• Zika Virus in the Male Reproductive Tract
  Liesel Stassen, Charles W. Armitage, David J. Van der Heide, Kenneth W. Beagley, Francesca D. Frentiu
  Viruses.2018; 10(4): 198.     CrossRef
• Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice
  Ran Wang, Xianzheng Liao, Dongying Fan, Lei Wang, Ji Song, Kaihao Feng, Mingyuan Li, Peigang Wang, Hui Chen, Jing An
  Vaccine.2018; 36(24): 3522.     CrossRef
• Zika knowledge and preventive practices among reproductive-age women from Lambayeque, Peru
  Sara J. Burgos-Muñoz, Carlos J. Toro-Huamanchumo
  European Journal of Obstetrics & Gynecology and Reproductive Biology.2018; 228: 255.     CrossRef
• A panoptic uncovering of the dynamical evolution of the Zika Virus NS5 methyltransferase binding site loops—zeroing in on the molecular landscape
  Nikita Devnarain, Mahmoud E. S. Soliman
  Chemical Biology & Drug Design.2018; 92(5): 1838.     CrossRef
• Structural view of the helicase reveals thatZika virususes a conserved mechanism for unwinding RNA
  Lei Li, Jin Wang, Zhihui Jia, Neil Shaw
  Acta Crystallographica Section F Structural Biology Communications.2018; 74(4): 205.     CrossRef
• Functional Genomics and Immunologic Tools: The Impact of Viral and Host Genetic Variations on the Outcome of Zika Virus Infection
  Sang-Im Yun, Byung-Hak Song, Jordan C. Frank, Justin G. Julander, Aaron L. Olsen, Irina A. Polejaeva, Christopher J. Davies, Kenneth L. White, Young-Min Lee
  Viruses.2018; 10(8): 422.     CrossRef
• Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro
  Ilaria Vicenti, Adele Boccuto, Alessia Giannini, Filippo Dragoni, Francesco Saladini, Maurizio Zazzi
  Virus Research.2018; 244: 64.     CrossRef
• The use of humanized mice for studies of viral pathogenesis and immunity
  Florian Douam, Alexander Ploss
  Current Opinion in Virology.2018; 29: 62.     CrossRef
• Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells
  Rupsa Basu, Lukai Zhai, Alice Contreras, Ebenezer Tumban
  Vaccine.2018; 36(10): 1256.     CrossRef
• Human Sertoli cells support high levels of Zika virus replication and persistence
  Anil Kumar, Juan Jovel, Joaquin Lopez-Orozco, Daniel Limonta, Adriana M. Airo, Shangmei Hou, Iryna Stryapunina, Chad Fibke, Ronald B. Moore, Tom C. Hobman
  Scientific Reports.2018;[Epub]     CrossRef
• Identification of genetic variants associated with dengue or West Nile virus disease: a systematic review and meta-analysis
  Megan E. Cahill, Samantha Conley, Andrew T. DeWan, Ruth R. Montgomery
  BMC Infectious Diseases.2018;[Epub]     CrossRef
• Zika virus and autoimmunity. One-step forward
  Diana M. Monsalve, Yovana Pacheco, Yeny Acosta-Ampudia, Yhojan Rodríguez, Carolina Ramírez-Santana, Juan-Manuel Anaya
  Autoimmunity Reviews.2017; 16(12): 1237.     CrossRef
• Recombinant Zika NS1 Protein Secreted from Vero Cells Is Efficient for Inducing Production of Immune Serum Directed against NS1 Dimer
  Wildriss Viranaicken, Alexia Ndebo, Sandra Bos, Philippe Souque, Gilles Gadea, Chaker El-Kalamouni, Pascale Krejbich-Trotot, Pierre Charneau, Philippe Desprès, Marjolaine Roche
  International Journal of Molecular Sciences.2017; 19(1): 38.     CrossRef
• Differential diagnosis of multiple sclerosis in Latin America
  YD Fragoso, FG Elso, A Carrá
  Multiple Sclerosis Journal - Experimental, Translational and Clinical.2017;[Epub]     CrossRef
• Microglia at center stage: a comprehensive review about the versatile and unique residential macrophages of the central nervous system
  Nils Lannes, Elisabeth Eppler, Samar Etemad, Peter Yotovski, Luis Filgueira
  Oncotarget.2017; 8(69): 114393.     CrossRef
• Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans
  Alba Grifoni, John Pham, John Sidney, Patrick H. O'Rourke, Sinu Paul, Bjoern Peters, Sheridan R. Martini, Aruna D. de Silva, Michael J. Ricciardi, Diogo M. Magnani, Cassia G. T. Silveira, Alvino Maestri, Priscilla R. Costa, Luzia Maria de-Oliveira-Pinto,
  Journal of Virology.2017;[Epub]     CrossRef
• Brain grants permission of access to Zika virus but denies entry to drugs: a molecular modeling perspective to infiltrate the boundary
  Nikita Devnarain, Pritika Ramharack, Mahmoud E. Soliman
  RSC Adv..2017; 7(75): 47416.     CrossRef
• Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections
  Xingcui Zhang, Renyong Jia, Haoyue Shen, Mingshu Wang, Zhongqiong Yin, Anchun Cheng
  Viruses.2017; 9(11): 338.     CrossRef

Citations

Citations to this article as recorded by  

• Harnessing Pentameric Scaffold of Cholera Toxin B (CTB) for Design of Subvirion Recombinant Dengue Virus Vaccine
  Jemin Sung, Yucheol Cheong, Young-Seok Kim, Jina Ahn, Myung Hyun Sohn, Sanguine Byun, Baik-Lin Seong
  Vaccines.2024; 12(1): 92.     CrossRef
• Global progress in clinical research on human respiratory syncytial virus vaccines
  Ruofan Peng, Chenghao Chen, Qian Chen, Yuwen Zhang, Renjin Huang, Yanjun Zhang, Jianhua Li
  Frontiers in Microbiology.2024;[Epub]     CrossRef
• Virus-like particles in poultry disease: an approach to effective and safe vaccination
  Abdullahi Abdullahi Raji, Paniz Zarghami Dastjerdi, Abdul Rahman Omar
  Frontiers in Veterinary Science.2024;[Epub]     CrossRef
• Sf9 Cell Metabolism Throughout the Recombinant Baculovirus and Rabies Virus-Like Particles Production in Two Culture Systems
  Luis Giovani Oliveira Guardalini, Jaci Leme, Paulo Eduardo da Silva Cavalcante, Renata Gois de Mello, Thaissa Consoni Bernardino, Simone Gonçalves Silva Jared, Marta Maria Antoniazzi, Renato Mancini Astray, Aldo Tonso, Eutimio Gustavo Fernández Núñez, Sor
  Molecular Biotechnology.2024; 66(2): 354.     CrossRef
• Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview
  Ruth Henríquez, Isabel Muñoz-Barroso
  Heliyon.2024; 10(15): e34927.     CrossRef
• Design and Application of Biosafe Coronavirus Engineering Systems without Virulence
  Guoqiang Wu, Qiaoyu Li, Junbiao Dai, Guobin Mao, Yingxin Ma
  Viruses.2024; 16(5): 659.     CrossRef
• Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter
  Sara Molenda, Agata Sikorska, Anna Florczak, Patryk Lorenc, Hanna Dams-Kozlowska
  Cancers.2023; 15(23): 5647.     CrossRef
• Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery
  Vartika Srivastava, Kripa N. Nand, Aijaz Ahmad, Ravinder Kumar
  Vaccines.2023; 11(2): 479.     CrossRef
• Viral protein-based nanoparticles (part 2): Pharmaceutical applications
  Rocio Mellid-Carballal, Sara Gutierrez-Gutierrez, Carmen Rivas, Marcos Garcia-Fuentes
  European Journal of Pharmaceutical Sciences.2023; 189: 106558.     CrossRef
• Current and emerging pharmacotherapy for respiratory syncytial virus (RSV) infection in infants
  Nicola Principi, Giovanni Autore, Serafina Perrone, Susanna Esposito
  Expert Opinion on Pharmacotherapy.2023; 24(6): 747.     CrossRef
• Viral Nanoparticles‐Mediated Delivery of Therapeutic Cargo
  Saba Zanganeh, Mohammad Doroudian, Zohreh R. Nowzari, Pourya Nasirmoghadas, Javid Sadri Nahand, Shima Sepehrpour, Mohsen Moghoofei
  Advanced Therapeutics.2023;[Epub]     CrossRef
• Emerging Trends and Future Challenges of Nanovaccine Delivery via Nasal Route
  Hitesh Kumar Dewangan, Akash Raghuvanshi, Kamal Shah
  Current Drug Targets.2023; 24(3): 261.     CrossRef
• A Virus-like Particle-Based F4 Enterotoxigenic Escherichia coli Vaccine Is Inhibited by Maternally Derived Antibodies in Piglets but Generates Robust Responses in Sows
  Kara-Lee Aves, Priscila R. Guerra, Ana H. Fresno, Mauro M. S. Saraiva, Eric Cox, Poul J. Bækbo, Morten A. Nielsen, Adam F. Sander, John E. Olsen
  Pathogens.2023; 12(12): 1388.     CrossRef
• Virus-like Particles as Antiviral Vaccine: Mechanism, Design, and Application
  Lei Zhang, Wen Xu, Xi Ma, XiaoJing Sun, JinBo Fan, Yang Wang
  Biotechnology and Bioprocess Engineering.2023; 28(1): 1.     CrossRef
• Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications
  Ernesto Garay, Diego Fontana, Lautaro Leschiutta, Ricardo Kratje, Claudio Prieto
  Applied Microbiology and Biotechnology.2022; 106(2): 579.     CrossRef
• Engineering Self-Assembling Protein Nanoparticles for Therapeutic Delivery
  Audrey Olshefsky, Christian Richardson, Suzie H. Pun, Neil P. King
  Bioconjugate Chemistry.2022; 33(11): 2018.     CrossRef
• Can Virus-like Particles Be Used as Synergistic Agent in Pest Management?
  Caroline Deshayes, Anne-Sophie Gosselin-Grenet, Mylène Ogliastro, Bruno Lapied, Véronique Apaire-Marchais
  Viruses.2022; 14(5): 943.     CrossRef
• Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
  Hasnat Tariq, Sannia Batool, Saaim Asif, Mohammad Ali, Bilal Haider Abbasi
  Frontiers in Microbiology.2022;[Epub]     CrossRef
• Development and characterization of monoclonal antibodies against red-spotted grouper nervous necrosis virus and their neutralizing potency in vitro
  Zhiqi Zhang, Jing Xing, Xiaoqian Tang, Xiuzhen Sheng, Heng Chi, Wenbin Zhan
  Aquaculture.2022; 560: 738562.     CrossRef
• Sendai virus particles carrying target virus glycoproteins for antibody induction
  Hiroshi Ishii, Midori Nakamura-Hoshi, Tsugumine Shu, Tetsuro Matano
  Vaccine.2022; 40(16): 2420.     CrossRef
• Emerging Frontiers in Vaccine Development: A Review of Changing Paradigm
  Ishan Ghosh, Mohit D. Gandhi
  Journal of Biosciences and Medicines.2022; 10(07): 123.     CrossRef
• An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
  Alessio Facciolà, Giuseppa Visalli, Antonio Laganà, Angela Di Pietro
  Vaccines.2022; 10(5): 819.     CrossRef
• RNA-assisted self-assembly of monomeric antigens into virus-like particles as a recombinant vaccine platform
  Beom Jeung Hwang, Yohan Jang, Soon Bin Kwon, Ji Eun Yu, Jongkwan Lim, Young Hoon Roh, Baik L. Seong
  Biomaterials.2021; 269: 120650.     CrossRef
• Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery
  Kingshuk Dutta, Ritam Das, Jewel Medeiros, S. Thayumanavan
  Biochemistry.2021; 60(13): 966.     CrossRef
• Engineering Tobacco Mosaic Virus and Its Virus‐Like‐Particles for Synthesis of Biotemplated Nanomaterials
  Kok Zhi Lee, Vindula Basnayake Pussepitiyalage, Yu‐Hsuan Lee, L. Sue Loesch‐Fries, Michael T. Harris, Shohreh Hemmati, Kevin V. Solomon
  Biotechnology Journal.2021;[Epub]     CrossRef
• Racing to immunity: Journey to a COVID‐19 vaccine and lessons for the future
  Ester Calvo Fernández, Lucie Y. Zhu
  British Journal of Clinical Pharmacology.2021; 87(9): 3408.     CrossRef
• Advanced Nanobiomedical Approaches to Combat Coronavirus Disease of 2019
  Halle Lutz, Kristen D. Popowski, Phuong-Uyen C. Dinh, Ke Cheng
  Advanced NanoBiomed Research.2021;[Epub]     CrossRef
• RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform
  Jongkwan Lim, Yucheol Cheong, Young-Seok Kim, Wonil Chae, Beom Jeung Hwang, Jinhee Lee, Yo Han Jang, Young Hoon Roh, Sang-Uk Seo, Baik L. Seong
  Nanomedicine: Nanotechnology, Biology and Medicine.2021; 37: 102438.     CrossRef
• Nano-based approaches in the development of antiviral agents and vaccines
  Yang Li, Yushuo Xiao, Yuchen Chen, Kun Huang
  Life Sciences.2021; 265: 118761.     CrossRef
• Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
  Saghi Nooraei, Howra Bahrulolum, Zakieh Sadat Hoseini, Camellia Katalani, Abbas Hajizade, Andrew J. Easton, Gholamreza Ahmadian
  Journal of Nanobiotechnology.2021;[Epub]     CrossRef
• VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases
  Aline Maria Vasconcelos Queiroz, Johny Wysllas de Freitas Oliveira, Cláudia Jassica Moreno, Diego M. A. Guérin, Marcelo Sousa Silva
  Vaccines.2021; 9(3): 220.     CrossRef
• Nervous Necrosis Virus-like Particle (VLP) Vaccine Stimulates European Sea Bass Innate and Adaptive Immune Responses and Induces Long-Term Protection against Disease
  Sofie Barsøe, Kerstin Skovgaard, Dagoberto Sepúlveda, Ansgar Stratmann, Niccolò Vendramin, Niels Lorenzen
  Pathogens.2021; 10(11): 1477.     CrossRef
• Long-Term Protection and Serologic Response of European Sea Bass Vaccinated with a Betanodavirus Virus-Like Particle Produced in Pichia pastoris
  Sofie Barsøe, Anna Toffan, Francesco Pascoli, Ansgar Stratmann, Tobia Pretto, Andrea Marsella, Mériem Er-Rafik, Niccolò Vendramin, Niels J. Olesen, Dagoberto Sepúlveda, Niels Lorenzen
  Vaccines.2021; 9(5): 447.     CrossRef
• Expression, Purification, and Characterization of Bovine Leukemia Virus-Like Particles Produced in Drosophila S2 Cells
  Natalia Olivero-Deibe, Lorena Tomé-Poderti, Federico Carrión, Sergio Bianchi, Martín Fló, Daniel Prieto, Florencia Rammauro, Andrés Addiego, Natalia Ibañez, Madelón Portela, Rosario Duran, Mabel Berois, Otto Pritsch
  Frontiers in Virology.2021;[Epub]     CrossRef
• Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle Vaccines
  Acharya Balkrishna, Vedpriya Arya, Akansha Rohela, Ashwani Kumar, Rachna Verma, Dinesh Kumar, Eugenie Nepovimova, Kamil Kuca, Naveen Thakur, Nikesh Thakur, Pankaj Kumar
  Vaccines.2021; 9(10): 1129.     CrossRef
• Baculovirus affinity removal in viral-based bioprocesses
  Mafalda G. Moleirinho, Rita P. Fernandes, Sofia B. Carvalho, Sandra Bezemer, Frank Detmers, Pim Hermans, Ricardo J.S. Silva, Paula M. Alves, Manuel J.T. Carrondo, Cristina Peixoto
  Separation and Purification Technology.2020; 241: 116693.     CrossRef
• Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
  Naru Zhang, Chaoqun Li, Shibo Jiang, Lanying Du
  Vaccines.2020; 8(3): 481.     CrossRef
• A Flow-Through Chromatographic Strategy for Hepatitis C Virus-Like Particles Purification
  Ricardo J. S. Silva, Mafalda G. Moleirinho, Ana S. Moreira, Alex Xenopoulos, Paula M. Alves, Manuel J. T. Carrondo, Cristina Peixoto
  Processes.2020; 8(1): 85.     CrossRef
• Virus-like particle vaccine displaying Toxoplasma gondii apical membrane antigen 1 induces protection against T. gondii ME49 infection in mice
  Min-Ju Kim, Su-Hwa Lee, Hae-Ji Kang, Ki-Back Chu, Hyunwoo Park, Hui Jin, Eun-Kyung Moon, Sung Soo Kim, Fu-Shi Quan
  Microbial Pathogenesis.2020; 142: 104090.     CrossRef
• Bacterial Production of Barley Stripe Mosaic Virus Biotemplates for Palladium Nanoparticle Growth
  Yu-Hsuan Lee, Kok Zhi Lee, Rachel G. Susler, Corren A. Scott, Longfei Wang, L. Sue Loesch-Fries, Michael T. Harris, Kevin V. Solomon
  ACS Applied Nano Materials.2020; 3(12): 12080.     CrossRef
• Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
  Carlotta Biagi, Arianna Dondi, Sara Scarpini, Alessandro Rocca, Silvia Vandini, Giulia Poletti, Marcello Lanari
  Vaccines.2020; 8(4): 672.     CrossRef
• Virus-like particle-display of the enterotoxigenic Escherichia coli heat-stable toxoid STh-A14T elicits neutralizing antibodies in mice
  Morten L. Govasli, Yuleima Diaz, Pål Puntervoll
  Vaccine.2019; 37(43): 6405.     CrossRef
• Protein and Peptide Biomaterials for Engineered Subunit Vaccines and Immunotherapeutic Applications
  Alexandra N. Tsoras, Julie A. Champion
  Annual Review of Chemical and Biomolecular Engineering.2019; 10(1): 337.     CrossRef
• Capsid containing virus like particle vaccine against Zika virus made from a stable cell line
  Himanshu Garg, Tugba Mehmetoglu-Gurbuz, Gregory M. Ruddy, Anjali Joshi
  Vaccine.2019; 37(48): 7123.     CrossRef
• Incorporation of CD40 ligand enhances the immunogenicity of tumor‑associated calcium signal transducer 2 virus‑like particles against lung cancer
  Wang Xi, Dong Ke, Long Min, Wang Lin, Zuo Jiahui, Lin Fang, Gao Zhaowei, Zhang Zhe, Chen Xi, Zhang Huizhong
  International Journal of Molecular Medicine.2018;[Epub]     CrossRef
• Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
  Young-Seok Kim, Ahyun Son, Jihoon Kim, Soon Bin Kwon, Myung Hee Kim, Paul Kim, Jieun Kim, Young Ho Byun, Jemin Sung, Jinhee Lee, Ji Eun Yu, Chan Park, Yeon-Sook Kim, Nam-Hyuk Cho, Jun Chang, Baik L. Seong
  Frontiers in Immunology.2018;[Epub]     CrossRef
• Nanoparticle vaccines against viral infections
  Fernando B. Sulczewski, Raquel B. Liszbinski, Pedro R. T. Romão, Luiz Carlos Rodrigues Junior
  Archives of Virology.2018; 163(9): 2313.     CrossRef
• Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71
  Xi Wang, Ke Dong, Min Long, Fang Lin, Zhaowei Gao, Lin Wang, Zhe Zhang, Xi Chen, Ying Dai, Huiping Wang, Huizhong Zhang
  Archives of Virology.2018; 163(7): 1851.     CrossRef
• Questions of bioethics and biosafety in the problem of biotechnology and use of vaccine for prevention of human infectious diseases
  V. Zadorozhna, N. Vynnyk
  Bulletin "Veterinary biotechnology".2018; 32(1): 459.     CrossRef
• MultiBac: from protein complex structures to synthetic viral nanosystems
  Martin Pelosse, Hannah Crocker, Barbara Gorda, Paul Lemaire, Jens Rauch, Imre Berger
  BMC Biology.2017;[Epub]     CrossRef
• Green Tea Catechin-Inactivated Viral Vaccine Platform
  Yun H. Lee, Yo H. Jang, Young H. Byun, Yucheol Cheong, Paul Kim, Young J. Lee, Yoon J. Lee, Je M. Sung, Ahyun Son, Hye M. Lee, Jinhee Lee, Seung W. Yang, Jae-Min Song, Baik L. Seong
  Frontiers in Microbiology.2017;[Epub]     CrossRef
• Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus
  Himanshu Garg, Melina Sedano, Gabrielle Plata, Erin B. Punke, Anjali Joshi, Michael S. Diamond
  Journal of Virology.2017;[Epub]     CrossRef